N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-2-[(5S,8aS)-7-(2-methoxyethyl)-5-(2-methylpropyl)-3,6-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl]acetamide
Chemical Structure Depiction of
N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-2-[(5S,8aS)-7-(2-methoxyethyl)-5-(2-methylpropyl)-3,6-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl]acetamide
N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-2-[(5S,8aS)-7-(2-methoxyethyl)-5-(2-methylpropyl)-3,6-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl]acetamide
Compound characteristics
Compound ID: | SB41-1013 |
Compound Name: | N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-2-[(5S,8aS)-7-(2-methoxyethyl)-5-(2-methylpropyl)-3,6-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl]acetamide |
Molecular Weight: | 435.52 |
Molecular Formula: | C21 H33 N5 O5 |
Smiles: | CC(C)C[C@H]1C(N(CCOC)C[C@H]2CN(CC(NCc3c(C)noc3C)=O)C(N12)=O)=O |
Stereo: | ABSOLUTE |
logP: | 0.9272 |
logD: | 0.9272 |
logSw: | -1.546 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 91.469 |
InChI Key: | POSNZYVXPHQTRJ-AEFFLSMTSA-N |